Icon Aktie [WKN: 914327 / ISIN: US45103T1079]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Icon plc (Spons. ADRS)

20.04.21		ICON wins multiple categories in 2021 CRO Leadership Awards for the fourth year in a row (Businesswire)
08.02.21		ICON Launches FIRECREST Safety Letters and Site Question Management Supporting Regulatory Compliance and Increasing Site Support (Businesswire)
04.01.21		ICON Supports Pfizer and BioNTech on the Investigational COVID-19 Vaccine Trial (Businesswire)
19.10.20		BARDA reselects ICON as preferred partner to help strengthen US emergency preparedness and response (Businesswire)
07.10.20		ICON Wins Best CRO at the Vaccine Industry Excellence Awards (Businesswire)
03.09.20		ICON Launches Accellacare a Global Clinical Research Network Focused on Increasing Patient Recruitment With a Patient Centric Approach (Businesswire)
21.08.20		Forbes names ICON in list of Best Employers in America for Women (Businesswire)
05.05.20		ICON Appoints New Chief Medical Officer (Businesswire)
09.04.20		ICON wins multiple categories in 2020 CRO Leadership Awards third year in a row (Businesswire)
05.12.19		ICON Wins Best Contract Research Organisation – Full-Service Providers at the 15th Annual Scrip Awards 2019 (Businesswire)
24.06.19		ICON and DIA Driving Insights to Action with DIA Live 2019 (Businesswire)
13.05.19		ICON Awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research (Businesswire)
09.05.19		ICON Launches New Patient Engagement Platform to Support Improved Patient Experience and Enrollment in Clinical Trials (Businesswire)
05.03.19		ICON Wins Multiple Categories in 2019 CRO Leadership Awards (Businesswire)
05.02.19		ICON Launches New Drug Safety Reporting Solution that Ensures Compliance through Automation (Businesswire)
25.10.18		ICON Wins Pharma Contract Services Company of the Year at the Pharma Industry Awards 2018 (Businesswire)
25.07.18		ICON Reports Second Quarter 2018 Results (Businesswire)
27.06.18		ICON Is Collaborating with Practice Fusion, Inc. to Advance Health Research (Businesswire)
11.06.18		ICON Enhances Endpoint Adjudication Services Using AG Mednet Advanced Technology (Businesswire)
21.05.18		ICON launches FIRECREST Financial Disclosure to Reduce Administrative Costs and Increase Regulatory Compliance (Businesswire)
16.05.18		ICON Named by Forbes as One of the Best Employers in America (Businesswire)
14.05.18		ICON Announces Clinical Research partnership with DuPage Medical Group (Businesswire)
09.05.18		ICON Sponsors Industry-Wide Clinical Trials Survey to Support Transforming Trials Initiative (Businesswire)
17.04.18		ICON Announces Agreement with Intel Allowing Integration of the Intel® Pharma Analytics Platform for Clinical Trials (Businesswire)
03.04.18		ICON Announces Launch of Government and Public Health Solutions to Support Global Public Health (Businesswire)
15.02.18		ICON Reports Fourth Quarter and Full Year 2017 Results (Businesswire)
09.01.18		ICON Issues Financial Guidance for Full Year 2018 (Businesswire)
09.01.18		ICON Appoints Dr. James Cummings as President of ClinicalRM (Businesswire)
30.11.17		ICON Wins Best Contract Research Organisation at the Annual Scrip Awards 2017 (Businesswire)
21.11.17		ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening (Businesswire)
16.11.17		MediMedia Managed Markets, an ICON Company, Wins Two Gold Industry Awards for Data Analytics and Healthcare Communications (Businesswire)
07.11.17		ICON Contributes to Major European Research Study That Aims to Improve Treatment for Traumatic Brain Injury (Businesswire)
06.11.17		ICON Reveals Voice-Assistant Applications for Clinical Trials at ISPOR Annual European Congress (Businesswire)
27.10.17		ICON and the International Consortium for Health Outcomes Measurement Unveil the World’s First Global Patient Outcomes Benchmarking Platform (Businesswire)
04.10.17		ICON Announces Appointment of Mr. Eugene McCague to Board of Directors (Businesswire)
27.07.17		ICON Reports Second Quarter 2017 Results (Businesswire)
26.07.17		ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting (Businesswire)
24.05.17		ICON and Regeneron Win Best Partnership in Clinical Research Award from PharmaTimes (Businesswire)
11.01.17		Research Reports Coverage on Healthcare Stocks -- Perrigo, Bruker, ICON, and HTG Molecular Diagnostics (PR Newswire)
09.01.17		ICON Issues Financial Guidance for Full Year 2017 (Businesswire)
27.10.16		ICON Further Enhances Clinical Trial Feasibility, Protocol Optimisation and Patient Recruitment Capabilities with TriNetX (Businesswire)
20.10.16		ICON Announces Executive Leadership Transition (Businesswire)
20.10.16		ICON Reports Third Quarter 2016 Results (Businesswire)
19.09.16		ICON Completes the Acquisition of Clinical Research Management, Inc. (Businesswire)
25.07.16		ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting (Businesswire)
30.06.16		ICON to Acquire Clinical Research Management, Inc. (Businesswire)
23.06.16		ICON: DIA Live to Provide a Digital Window into DIA Conference 2016 (Businesswire)
15.06.16		New Research from ICON Demonstrates Support for ‘Bring Your Own Device’ Approach in Clinical Trials (Businesswire)
10.06.16		ICON Signs 3-year Deal With Pfizer; Terms Not Disclosed - Quick Facts (RTTNews)
10.06.16		ICON Announces Service Agreement with Pfizer (Businesswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

Krypto-Influencer prognostiziert für 2025 gewaltige Rally beim Dogecoin

Solana Kurs-Prognose: 300 US-Dollar noch im Januar?

Neuer Stablecoin RLUSD: Ripple setzt auf globale Verfügbarkeit

SEC intensiviert Maßnahmen gegen Elon Musk und nimmt Neuralink unter die Lupe

Krypto-News: Während der Bitcoin konsolidiert pumpen Solana, Ripple und der Dogecoin

Zinspolitik 2025: EZB plant Senkungen - wie schnell kommen sie?

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	06.01.2025 09:37
Kaufwert:	EUR
	Hinzufügen Speichern